314-514-8509 Toll-Free: 1-866-758-7425

Google+ Page Link  Facebook Page Link  Linkedin Page Link

Current Studies

 The Clinical Research Center conducts research studies in the areas of Asthma, Allergy and COPD.  We frequently update this page with our current study information so check back often.

  Please e-mail Becky or Monica at This email address is being protected from spambots. You need JavaScript enabled to view it. or call 314-514-8509 to see if you qualify for a study. 

 test

 

1. Are you Currently Experiencing Symptoms of COPD? 

2. Are You Interested in Evaluating an Investigational Medication for COPD?

3Have You Taken Prednisone or Visited the ER for Asthma in the Past Year?

4. Are You Currently Treating your COPD with a Daily Medication?

5. Are You Currently Treating Your Asthma with Daily Medication?

 

 

 

 

 You can also sign-up for our monthly newsletter that contains information on current St. Louis Research Studies at CRC and additional updates in the world of Asthma, Allergy and COPD.

 

1.  Are you experiencing symptoms of your COPD?

The Clinical Research Center is evaluating the safety and efficacy of an investigational medication for COPD.  The study consists of 6 office visits over approximately 22 weeks.  The study medication will be delivered by inhaler.

To Qualify:

  • You must be at least 40 years old
  • You must have a diagnosis of COPD
  • You must be experiencing symptoms on a consistent basis with your COPD
  • You must be a current or former smoker with at least a 10 year pack history
  • You must not have a diagnosis of any other lung condition other than COPD
  • You must not have had more than one COPD exacerbation that required treatment with antibiotics or oral steriods in the past 12 months
  • You must not have been hospitalized for your COPD within the past 12 months

 

2. Are you interested in evalutating an investigational medication for COPD?

 The Clinical Research Center is conducting a placebo controlled study to evaluate an investigational medication for COPD.  The study medication is a bio-equivalent medication to Spiriva.  Your participation in the study could last up to 26 weeks and consist of up to 8 visits.

To Qualify:

  • You must be over the age of 40
  • You must be using albuterol only to treat your COPD or be willing to change your current COPD medications for the duration of the study
  • You must be a current or former smoker with a pack year history of at least 10 years
  • You must not use oxygen for more than 12hrs a day
  • You must not have irregular day/night, waking/sleeping cycles, i.e. night shift workers 

 

 3. Have you visited the ER or taken Prednisone for your Asthma in the past year?

The Clinical Research Center is conducting a clinical trial to evaluate an investigational medication for Asthma.  The study medication will be delivered by injection every 4 weeks.  The study consists of 19 visits over approximately 73 weeks.

To Qualify:

  • You must be between the ages of 18-75
  • You must currently be treating your asthma with inhaled corticosteriods, plus another maintence inhaler and have been using both for at least the past 3 months
  • You must have a BMI between 18-35
  • You must have had a documented asthma exacerbation while on your current treatment at least once in the past 12 months
  • You must be experiencing frequent asthma symptoms despite daily treatment
  • You must be a non-smoker or a former smoker with a pack year history of less than 10
  • You must have a diagnosis of Asthma for at least 12 months

 

4. Are you currently treating you COPD with a daily medication?

The Clinical Research Center is conducting a clinical trial to evaluate a investigational COPD medication.  The study consists of 5-7 visits over approximately 10 weeks.  The study does include a placebo arm.

To Qualify:

  • You must be 40 years of age or older
  • You must have a diagnosis of COPD for at least a year
  • You must currently be currently treating your COPD with a daily medication for at least 8 weeks prior to starting the study 
  • You must be a current or former smoker with at least a 10 pack year history

  

 

5. Are you currently treating your asthma with a daily medication?

The Clinical Research Center in West St. Louis County is evaluating the effectiveness of an investigational inhaler versus Symbicort 80/4.5.  The study is placebo-controlled. The study consists of 3-4 office visits over approximately 8-10 weeks.

To Qualify:

  • You Must be 18 years of age or older
  • You Must be diagnosed with asthma for at least six months
  • You Must be using a daily maintenance inhaler at a stable dose for the past 4 weeks
  • You cannot have a history of life-theatening asthma, including intubation or seizures due to lack of oxygen
  • You cannot have visited the ER or Urgent Care for your asthma or have been hospitalized for asthma in the past year
  • You cannot be a current smoker or a former smoker with a pack year history greater than 10